Atlas Trials

A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection

Clinical trial NCT06615921 · COMPLETED

Trial details

NCT number
NCT06615921
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Cytomegalovirus (CMV)
Start date
2024-10-14
Primary completion
2025-07-04
Enrollment
265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.